Medicamen Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Medicamen Biotech	Jenburkt Pharma	Shivalik Rasayan
Operational Metrics
Financials
5 yr Average ROE	6.92 %	18.49 %	6.54 %
5yr average Equity Multiplier	1.44	1.17	1.82
5yr Average Asset Turnover Ratio	0.55	0.88	0.44
5yr Avg Net Profit Margin	8.69 %	18.1 %	7.94 %
Price to Book	1.76	2.49	0.82
P/E	45.38	13.83	34.08
5yr Avg Cash Conversion Cycle	49.75 Days	-32.02 Days	100.7 Days
Inventory Days	84.58 Days	24.72 Days	80.64 Days
Days Receivable	139.4 Days	48.38 Days	107.04 Days
Days Payable	264.75 Days	82.6 Days	166.18 Days
5yr Average Interest Coverage Ratio	7.03	87.2	8.55
5yr Avg ROCE	10.34 %	24.44 %	8.54 %
5yr Avg Operating Profit Margin	15.51 %	22.46 %	17.6 %
5 yr average Debt to Equity	0.15	0.02	0.2
5yr CAGR Net Profit	-11.57 %	14.21 %	-1.04 %
5yr Average Return on Assets	4.73 %	15.8 %	3.57 %
Shareholdings
Promoter Holding	40.46 %	46.65 %	47.37 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.75 %	0.68 %	-2.95 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Medicamen Biotech	Jenburkt Pharma	Shivalik Rasayan
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals Formulations 100.0 Pharmaceuticals 0 Dermatology 0 ACTIVE PHARMA INGREDIENT 0 Pharma 0 Agrochemicals 0	Product Wise Break-Up Dermatology 0 Pharmaceutical 100.0 Pharma 0 Agrochemicals 0 Pharmaceuticals Formulations 0 ACTIVE PHARMA INGREDIENT 0	Product Wise Break-Up Dermatology 0 Pharmaceuticals 0 Pharmaceutical 50.27 Agro Chemicals 47.29 Pharmaceuticals Formulations 0 ACTIVE PHARMA INGREDIENT 1.55 Others 0.89
Location Wise Break-Up	Location Wise Break-Up India 20.0 Rest of the World 0 Others 80.0	Location Wise Break-Up India 87.23 Rest of the World 12.56 Others 0.21	-